![Javier San Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Javier San Martin
Chief Tech/Sci/R&D Officer at
LEONABIO, INC.
Net worth: 151 562 $ as of 2026-05-30
Profile
Presently, Javier San Martin is Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. He previously held the position of Executive Director-Bone Therapeutic Area at Amgen, Inc., Principal at Eli Lilly & Co., Senior VP-Global Clinical Development at Ultragenyx Pharmaceutical, Inc. and Senior Vice President-Clinical Development at Alder Biopharmaceuticals, Inc. He received a doctorate from Universidad de Buenos Aires.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEONABIO, INC. 0.17% | 2026-04-30 | 15,887 ( 0.17% ) | 151 562 $ | 2026-05-30 |
Javier San Martin active positions
| Companies | Position | Start |
|---|---|---|
| LEONABIO, INC. | Chief Tech/Sci/R&D Officer | 2024-04-14 |
Former positions of Javier San Martin
| Companies | Position | End |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2024-01-31 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 2019-10-31 |
| AMGEN INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Javier San Martin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
University of Buenos Aires School of Medicine
 University of Buenos Aires School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Javier San Martin
